Japan Intellectual Property Rights: POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS

Japan, March 23 -- MERCK PATENT GMBH has got intellectual property rights for 'POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS.' Other related details are as follows:

Application Number: JP,2023-117597

Category (FI): A61K31/454,A61K31/4545,A61K31/4709,A61K31/496,A61K31/498,A61K31/4985,A61K31/517,A61K31/519,A61K31/5377,A61K31/551,A61P1/04,A61P1/14,A61P13/12,A61P17/00,A61P17/06,A61P19/02,A61P19/04,A61P19/06,A61P19/10,A61P25/00,A61P25/16,A61P25/28,A61P29/00,A61P29/00,101,A61P3/10,A61P31/04,A61P35/00,A61P43/00,105,A61P43/00,111,A61P9/10,A61P9/10,101,C07D241/42,C07D401/04,C07D401/14,C07D405/14,C07D413/04,C07D413/14,C07D417/04,C07D451/02,C07D471/04,C07D471/04,104@Z,C07D471/04,113,C07D471/04,114@A,C07D471/04,116,C07D471/04,117@N,C07D471/04,120,C07D487/04,143

Stage: Grant (IP right document published.)

Filing Date: July 19, 2023

Publication Date: Sept. 7, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.